from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3321c/vapB44

LFCtreatmentdescriptionclass of inhibitor

1.242

Amikacinug/mL Amikacintranslation

1.259

Cap5-10ug/mL Capreomycintranslation

1.338

Rox10-50 ug/mL Roxithromycintranslation

0.997

SM2-5 ug/mL Streptomycintranslation

2.918

Tet5-10 ug/mL Tetracyclinetranslation

-0.177

Rif0.2-5ug/mL Rifampicintranscription

0.040

Rifp0.1-0.5ug/mL Rifapentinetranscription

-2.495

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.817

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.090

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.350

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.162

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.173

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.788

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.377

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.379

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.284

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.219

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.119

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.813

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.929

KCN5-20 ug/mL Potassium cyaniderespiration

-0.765

NaN30.2-2 mM Sodium aziderespiration

1.344

Nigericin50 uM Nigericinrespiration

-0.293

TRC10-150 ug/mL Triclosanrespiration

-0.670

TRZ10-25 ug/mL Thioridazinerespiration

-0.240

Valinomycin0.5-10 uM Valinomycinrespiration

0.015

ZnSO42 mM ZnSO4respiration

0.691

menadione6-10 ug/mL Menadionerespiration

0.080

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.813

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.327

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.886

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-3.487

NRP_1Non-replicating persistence stage 1dosRassociated

0.387

Amp0.2mg/mL AmpicillincellWall

0.822

Cephalexin20-100 ug/mL CephalexincellWall

0.953

Cerulenin0.32-5 ug/mL CerulenincellWall

0.398

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.105

EMB10-20 ug/mL EthambutolcellWall

0.605

Eta12-40 ug/mL EthionamidecellWall

1.355

INH0.2-0.4 ug/mL IsoniazidcellWall

0.287

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.302

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.715

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.023

BZA0.12 mg/mL BenzamidearomaticAmides

-0.179

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.301

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.698

H2O24 mM hydrogen peroxideDNAdamaging

0.196

Levo10 ug/mL LevofloxacinDNAdamaging

-0.000

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.009

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.608

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.111

UVUV-irradiationDNAdamaging

-0.604

ARP41-4 ug/mL Antitubercular compound ARP4?

0.306

Antimycin12.5-50 ug/mL Antimycin A?

0.445

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

1.093

PA_110-50 ug/mL Antitubercular compound PA-1?

0.541

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.330

PA8240.2-2 ug/mL PA-824?

-0.933

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.064

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.429

Verapamil50 uM Verapamil?

0.185

mercaptoethanol2 mM 2-Mercaptoethanol?

0.603

methoxatin10-20 ug/mL Methoxatin?